Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Good morning. I’ve fallen ...

BridgeBio Pharma is a biotechnology company focused on bridging the gap between genetic research and unmet patient needs. Its pipeline targets Mendelian disorders, precision oncology, and gene therapy ...

- Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modulating properties, and the execution of high-value ...

Clinical research is evolving rapidly. Trials are more complex, data sources keep expanding, and regulators expect greater transparency and reproducibility. In parallel, AI is transforming how data is ...

Applied Digital's sales rose by 250% in its fiscal 2026 second quarter. Its expenses rose by 230%, and the company is still unprofitable. Applied Digital's stock is expensive, and the tech sector's ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

For years, public debate around U.S. dependence on China has focused on semiconductors, consumer electronics, rare earth minerals and industrial manufacturing. Far less attention has been paid to a ...

For this Model 10+ Portfolio series, I believe it's important to note a major change which is the removal of #10 VistaGen Therapeutics (VTGN). The reason why is because it recently reported topline ...

Of 38 efficacy-evaluable patients, the overall (cumulative) major molecular response (MMR) rate was 74% (28/38) by 24 weeks, with 64% (18/28) achieving MMR and 100% (10/10) maintaining MMR. Also Read: ...

Richarlison is slowly getting into his groove this season for Tottenham Hotspur. Tottenham Hotspur fans have been so used to Harry Kane and Son Heung-min leading the attack that many have not been ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...